Tanvex BioPharma, Inc. (TPE:6541)

Taiwan · Delayed Price · Currency is TWD

48.10

-0.90 (-1.84%)

Feb 11, 2026, 1:30 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Biotechnology (Startups)	34.68M	61.41M	22.40M	5.41M	300.00K
Biotechnology (Startups) Growth	-43.53%	174.11%	314.43%	1702.00%	-
Total	34.68M	61.41M	22.40M	5.41M	300.00K
Total Growth	-43.53%	174.11%	314.43%	1702.00%	-

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Taiwan	-	53.70M	22.40M	5.41M	300.00K
Taiwan Growth	-	139.70%	314.43%	1702.00%	-
United States	34.68M	7.71M	-	-	-
United States Growth	349.84%	-	-	-	-
Total	34.68M	61.41M	22.40M	5.41M	300.00K
Total Growth	-43.53%	174.11%	314.43%	1702.00%	-

Source: S&P Global Market Intelligence.